ISRCTN58113014
Completed
未知
Effect on the incidence of exacerbations of a programme of physical activity encouragement using pedometers in patients with Chronic Obstructive Pulmonary Disease: A randomized multicenter clinical trial
Agencia Nacional de Investigación y Desarrollo0 sites22 target enrollmentJuly 2, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Exacerbations in patients with Chronic Obstructive Pulmonary Disease
- Sponsor
- Agencia Nacional de Investigación y Desarrollo
- Enrollment
- 22
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. COPD patients
- •2\. 40 years old and older
- •3\. Ex smokers
Exclusion Criteria
- •1\. Exacerbations until 2 months before recruitment
- •2\. Not able to walk
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Cardiac Arrhythmias in early ICU stay and mortality.Health Condition 1: R008- Other abnormalities of heart beatHealth Condition 2: R009- Unspecified abnormalities of heartbeatCTRI/2023/01/048728Fortis hospitals limited
Completed
Not Applicable
Observational study on effects of acute exacerbation on physical activity in COPDChronic obstructive pulmonary disease (COPD)JPRN-UMIN000021364Department of pulmonary medicine, graduate school of medical & dental sciences, Kagoshima University30
Recruiting
Not Applicable
nreported symptomatic exacerbation and progressive pulmonary fibrosis in patients with interstitial lung disease: prospective observational study using a disease management system (YaDoc)Interstitial Lung DiseaseJPRN-UMIN000049420Tosei General Hospital40
Recruiting
Phase 1
Study on the regularity of the occurrence of acute myocardial infarction based on the five yun and six qi theory and circadian genesacute myocardial infarctionITMCTR2100004515Dongzhimen Hospital, Beijing University of Chinese Medicine
Active, not recruiting
Not Applicable
?The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms? pattern, in patients with gastroesophageal reflux disease (GERD). A randomized, double-blind, placebo controlled study? - NDgastroesaphageal reflux disease (GERD)MedDRA version: 9.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux diseaseEUCTR2007-003478-25-ITROTTAPHARM / ROTTA RESEARCH LABORATORIUM